Header
Header
Article

STN-DBS does not increase the risk of sialorrhea in patients with advanced Parkinson’s disease


  • Fasano, A. et al. Motor and cognitive outcome in patients with Parkinson’s disease 8 years after subthalamic implants. Brain 133, 2664–2676 (2010).

    Article 

    Google Scholar
     

  • Bove, F. et al. Long-term outcomes (15 years) after subthalamic nucleus deep brain stimulation in patients with parkinson’s disease. Neurology 97, e254–e262 (2021).

    Article 

    Google Scholar
     

  • Dafsari, H. S. et al. Beneficial effects of bilateral subthalamic stimulation on non-motor symptoms in Parkinson’s disease. Brain Stimul. 9, 78–85 (2016).

    Article 

    Google Scholar
     

  • Bellini, G., Best, L. A., Brechany, U., Mills, R. & Pavese, N. Clinical impact of deep brain stimulation on the autonomic system in patients with Parkinson’s disease. Mov. Disord. Clin. Practice 7, 373–382 (2020).

    Article 

    Google Scholar
     

  • Fasano, A., Visanji, N. P., Liu, L. W., Lang, A. E. & Pfeiffer, R. F. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol. 14, 625–639 (2015).

    CAS 
    Article 

    Google Scholar
     

  • Rana, A. Q. et al. Impact of cognitive dysfunction on drooling in Parkinson’s disease. Eur. Neurol. 70, 42–45 (2013).

    Article 

    Google Scholar
     

  • Srivanitchapoom, P., Pandey, S. & Hallett, M. Drooling in Parkinson’s disease: a review. Parkinsonism Relat. Disord. 20, 1109–1118 (2014).

    Article 

    Google Scholar
     

  • Rodrigues, B., Nobrega, A. C., Sampaio, M., Argolo, N. & Melo, A. Silent saliva aspiration in Parkinson’s disease. Mov. Disord. 26, 138–141 (2011).

    Article 

    Google Scholar
     

  • Xie, T. et al. Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD. J. Neurol. Neurosurg. Psychiatry 89, 989–994 (2018).

    Article 

    Google Scholar
     

  • Chang, M. C., Park, J. S., Lee, B. J. & Park, D. The effect of deep brain stimulation on swallowing function in Parkinson’s disease: a narrative review. Dysphagia 36, 786–799 (2021).

    Article 

    Google Scholar
     

  • Thobois, S. et al. Subthalamic nucleus stimulation in Parkinson’s disease: clinical evaluation of 18 patients. J. Neurol. 249, 529–534 (2002).

    CAS 
    Article 

    Google Scholar
     

  • Rizzone, M. G. et al. Long-term outcome of subthalamic nucleus DBS in Parkinson’s disease: from the advanced phase towards the late stage of the disease? Parkinsonism Relat. Disord. 20, 376–381 (2014).

    CAS 
    Article 

    Google Scholar
     

  • Defer, G. L., Widner, H., Marie, R. M., Remy, P. & Levivier, M. Core assessment program for surgical interventional therapies in Parkinson’s disease (CAPSIT-PD). Mov. Disord. 14, 572–584 (1999).

    CAS 
    Article 

    Google Scholar
     

  • Perez-Lloret, S. et al. Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson’s disease: preliminary analysis from the French COPARK cohort. Eur. J. Neurol. 19, 28–37 (2012).

    CAS 
    Article 

    Google Scholar
     

  • Martinez-Martin, P. et al. Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease. J. Neurol. 259, 1639–1647 (2012).

    Article 

    Google Scholar
     

  • Fereshtehnejad, S. M., Skogar, O. & Lokk, J. Evolution of orofacial symptoms and disease progression in idiopathic Parkinson’s disease: longitudinal data from the Jonkoping Parkinson registry. Parkinsons Dis. 2017, 7802819 (2017).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Savica, R. et al. Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol. 70, 1396–1402 (2013).

    Article 

    Google Scholar
     

  • Nobrega, A. C. et al. Is drooling secondary to a swallowing disorder in patients with Parkinson’s disease? Parkinsonism Relat. Disord. 14, 243–245 (2008).

    Article 

    Google Scholar
     

  • van Wamelen, D. J. et al. Drooling in Parkinson’s disease: prevalence and progression from the non-motor international longitudinal study. Dysphagia 35, 955–961 (2020).

    Article 

    Google Scholar
     

  • Hacker, M. L. et al. Deep brain stimulation in early-stage Parkinson disease: five-year outcomes. Neurology 95, e393–e401 (2020).

    Article 

    Google Scholar
     

  • Hughes, A. J., Daniel, S. E., Kilford, L. & Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55, 181–184 (1992).

    CAS 
    Article 

    Google Scholar
     

  • Fasano, A. et al. Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth. Clin. Neuropharmacol. 37, 91–95 (2014).

    CAS 
    Article 

    Google Scholar
     

  • Piano, C. et al. An Italian neurology outpatient clinic facing SARS-CoV-2 pandemic: data from 2,167 patients. Front Neurol. 11, 564 (2020).

    Article 

    Google Scholar
     

  • Fahn, S., Elton, R. & and Members of the UPDRS Development Committee. in Recent Developments in Parkinson’s Disease Vol. 2 (eds. Fahn, S., Marsden, C.D., Calne, D.B. & Goldstein, M.) 153–163 (Macmillan Healthcare Information, 1987).

  • Hoehn, M. M. & Yahr, M. D. Parkinsonism: onset, progression and mortality. Neurology 17, 427–442 (1967).

    CAS 
    Article 

    Google Scholar
     

  • Tomlinson, C. L. et al. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov. Disord. 25, 2649–2653 (2010).

    Article 

    Google Scholar
     



  • Source link

    Back to top button